These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9019589)

  • 1. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract].
    Kotschy M; Kałuzny J; Kaniasty M; Zekanowska E; Kropińska E
    Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor].
    Giedrojć J; Stankiewicz A; Walkowiak M; Galar M; Bielawiec M
    Klin Oczna; 1996; 98(4):283-5. PubMed ID: 9463119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasminogen activator and PAI. Detection in aqueous humor of the human eye].
    Steinkamp GW; Hattenbach LO; Heider HW; Scharrer I
    Ophthalmologe; 1993 Feb; 90(1):73-5. PubMed ID: 8443455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased basal levels of free plasminogen activator activity found in human aqueous humor.
    Wang Y; Taylor DM; Smalley DM; Cone RE; O'Rourke J
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3561-6. PubMed ID: 8056534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator activity in human aqueous humor.
    Smalley DM; Fitzgerald JE; Taylor DM; Cone RE; O'Rourke J
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):48-53. PubMed ID: 8300363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator in human aqueous humor.
    Bernatchez SF; Tabatabay C; Belin D
    Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2687-92. PubMed ID: 1639615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
    Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
    Hayashi K; Nakashima Y; Sueishi K; Tanaka K
    Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of fibrynolysis in children with chronic B or C hepatitis].
    Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
    Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
    Pedersen OD; Gram J; Jespersen J
    Thromb Haemost; 1995 May; 73(5):835-40. PubMed ID: 7482412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
    Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post-mortem concentration of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in the vitreous body of the human eye].
    Przygońska J; Kotschy M; Sliwka K; Kulwas A
    Klin Oczna; 1996 Mar; 98(3):205-8. PubMed ID: 9019590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
    Wu S; He X
    Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D
    J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue plasminogen activator, its inhibitor and other parameters of fibrinolysis in blood of patients operated for mild hypertrophy of the prostate].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F; Cwiklińska-Jurkowska M
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1096-7. PubMed ID: 1284828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.